journal article·2018-11-05Open access

Injectable visible light-cured glycol chitosan hydrogels with controlled release of anticancer drugs for local cancer therapy in vivo: a feasible study

Hoon Hyun, Min Ho Park, Wonbong Lim, So Yeon Kim, Danbi Jo, Jin Seok Jung, Gayoung Jo, Sewook Um, Deok-Won Lee, Dae Hyeok Yang

Abstract

Currently available chemotherapy is associated with serious side effects, and therefore novel drug delivery systems (DDSs) are required to specifically deliver anticancer drugs to targeted sites. In this study, we evaluated the feasibility of visible light-cured glycol chitosan (GC) hydrogels with controlled release of doxorubicin⋅hydrochloride (DOX⋅HCl) as local DDSs for effective cancer therapy in vivo. The storage modulus of the hydrogel precursor solutions was increased as a function of visible light irradiation time. In addition, the swelling ratio of the hydrogel irradiated for 10 s (GC10/DOX) was greater than in 60 s (GC60/DOX). In vitro release test showed that DOX was rapidly released in GC10/DOX compared with GC60/DOX due to the density of cross-linking. In vitro and in vivo tests including cell viability and measurement of tumor volume showed that the local treatment of GC10/DOX yielded substantially greater antitumor effect compared with that of GC60/DOX. Therefore, the visible light-cured GC hydrogel system may exhibit clinical potential as a local DDS of anticancer drugs with controlled release, by modulating cross-linking density.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · Advancements in Transdermal Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Sciences, Chonnam National University Medical School, Gwangju, Republic of Korea;

Department of Surgery, Chonnam National University Medical School, Gwangju, Republic of Korea;

Department of Premedical Program, School of Medicine, Chosun University, Gwangju, Republic of Korea;

Department of Dental Hygiene, College of Health Sciences, Cheongju University, Cheongju, Republic of Korea;

Department of Veterinary Surgery, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea;

Department of Oral and Maxillofacial Surgery, Kyung Hee University Dental Hospital at Gangdong, Kyung Hee University, Seoul, Republic of Korea;

Institute of Cell and Tissue Engineering, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

Funding

National Research Foundation of Korea

References (40)

Show source-provided references
1. 10.1016/j.jconrel.2011.11.03110.1016/j.jconrel.2011.11.031 ↗
2. 10.1002/adfm.20150068010.1002/adfm.201500680 ↗
3. 10.1021/bm500300910.1021/bm5003009 ↗
4. 10.1016/j.drudis.2016.07.00610.1016/j.drudis.2016.07.006 ↗
5. 10.1080/1071754059095262710.1080/10717540590952627 ↗
6. 10.1016/j.jconrel.2016.09.03410.1016/j.jconrel.2016.09.034 ↗
7. 10.3390/ijms14061222210.3390/ijms140612222 ↗
8. 10.1016/j.jiec.2017.05.00710.1016/j.jiec.2017.05.007 ↗
9. 10.3390/molecules2209151310.3390/molecules22091513 ↗
10. 10.1038/srep0687810.1038/srep06878 ↗
11. 10.2217/nnm.14.9910.2217/nnm.14.99 ↗
12. 10.1016/j.carbpol.2016.02.02910.1016/j.carbpol.2016.02.029 ↗
13. 10.1039/C4TB01971G10.1039/C4TB01971G ↗
14. 10.1016/j.bbamcr.2005.12.00810.1016/j.bbamcr.2005.12.008 ↗
15. 10.1038/bcj.2013.1510.1038/bcj.2013.15 ↗
16. 10.1016/j.actbio.2011.12.03410.1016/j.actbio.2011.12.034 ↗
17. Atsumi T · J Dent Res · 2000 · 9 · 75
18. 10.1016/j.biomaterials.2008.09.03710.1016/j.biomaterials.2008.09.037 ↗
19. 10.1007/s11426-014-5069-z10.1007/s11426-014-5069-z ↗
20. 10.1039/C7CC09313F10.1039/C7CC09313F ↗
21. 10.1039/C6PY02034H10.1039/C6PY02034H ↗
22. 10.1021/bm061006510.1021/bm0610065 ↗
23. 10.1039/C7TB02173A10.1039/C7TB02173A ↗
24. Deepa G · Int J Nanomed · 2012 · 7 · 4077
25. 10.1016/j.ejpb.2006.12.01410.1016/j.ejpb.2006.12.014 ↗
26. Riva R · 244 · 1910.1007/12_2011_137 ↗
27. 10.1016/j.jconrel.2013.08.29710.1016/j.jconrel.2013.08.297 ↗
28. 10.1016/j.jconrel.2007.12.01410.1016/j.jconrel.2007.12.014 ↗
29. 10.1016/j.jconrel.2008.01.01310.1016/j.jconrel.2008.01.013 ↗
30. 10.1016/j.jconrel.2008.02.00310.1016/j.jconrel.2008.02.003 ↗
31. 10.1016/S0168-3659(00)00280-710.1016/S0168-3659(00)00280-7 ↗
32. 10.1007/s11060-005-9001-410.1007/s11060-005-9001-4 ↗
33. Lesniak MS · Anticancer Res · 2005 · 25 · 3825
34. 10.1016/j.jconrel.2004.11.01410.1016/j.jconrel.2004.11.014 ↗
35. 10.1016/j.jconrel.2006.09.00710.1016/j.jconrel.2006.09.007 ↗
36. 10.1016/S0168-3659(98)00009-110.1016/S0168-3659(98)00009-1 ↗
37. 10.1002/cpt1973144part159210.1002/cpt1973144part1592 ↗
38. 10.1016/j.biomaterials.2004.11.01410.1016/j.biomaterials.2004.11.014 ↗
39. 10.1002/jps.2364910.1002/jps.23649 ↗
40. Wang Y · Int J Nanomed · 2015 · 10 · 7359